174 related articles for article (PubMed ID: 21629067)
21. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry.
Crespo EM; Oliveira GB; Honeycutt EF; Becker RC; Berger PB; Moliterno DJ; Anstrom KJ; Abrams CS; Kleiman NS; Moll S; Rice L; Rodgers JE; Steinhubl SR; Tapson VF; Granger CB; Ohman EM;
Am Heart J; 2009 Apr; 157(4):651-7. PubMed ID: 19332191
[TBL] [Abstract][Full Text] [Related]
22. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
Hauer KE
West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
[TBL] [Abstract][Full Text] [Related]
23. Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?
Lubenow N; Hinz P; Ekkernkamp A; Greinacher A
Eur J Haematol; 2007 Sep; 79(3):187-90. PubMed ID: 17655709
[TBL] [Abstract][Full Text] [Related]
24. Arterial and venous complications of heparin-induced thrombocytopenia in burn patients.
Scott JR; Klein MB; Gernsheimer T; Honari S; Gibbons J; Gibran NS
J Burn Care Res; 2007; 28(1):71-5. PubMed ID: 17211203
[TBL] [Abstract][Full Text] [Related]
25. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.
Sartori M; Favaretto E; Migliaccio L; Guazzaloca G; Legnani C; Palareti G; Cosmi B
Thromb Res; 2016 Mar; 139():154-7. PubMed ID: 26916314
[TBL] [Abstract][Full Text] [Related]
26. [Thrombosis prophylaxis with heparins in intensive care patients].
Greinacher A; Janssen D
Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Mar; 40(3):156-63. PubMed ID: 15770559
[TBL] [Abstract][Full Text] [Related]
27. Heparin-induced thrombocytopenia: diagnosis and management.
Hassell K
Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
[TBL] [Abstract][Full Text] [Related]
28. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis.
Alving BM; Krishnamurti C
Semin Thromb Hemost; 1997; 23(6):569-74. PubMed ID: 9469632
[TBL] [Abstract][Full Text] [Related]
29. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin.
Lindhoff-Last E; Nakov R; Misselwitz F; Breddin HK; Bauersachs R
Br J Haematol; 2002 Sep; 118(4):1137-42. PubMed ID: 12199798
[TBL] [Abstract][Full Text] [Related]
30. Heparin-induced thrombocytopenia: an uncommon but serious complication of heparin use in renal replacement therapy.
Charif R; Davenport A
Hemodial Int; 2006 Jul; 10(3):235-40. PubMed ID: 16805883
[TBL] [Abstract][Full Text] [Related]
31. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.
Warkentin TE; Roberts RS; Hirsh J; Kelton JG
Arch Intern Med; 2003 Nov; 163(20):2518-24. PubMed ID: 14609790
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of heparin-induced thrombocytopenia.
Kouides PA; Fricke W
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):335-45. PubMed ID: 15853606
[TBL] [Abstract][Full Text] [Related]
33. Current practice of thromboprophylaxis in the burn population: a survey study of 84 US burn centers.
Ferguson RE; Critchfield A; Leclaire A; Ajkay N; Vasconez HC
Burns; 2005 Dec; 31(8):964-6. PubMed ID: 16269216
[TBL] [Abstract][Full Text] [Related]
34. Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients.
Kato S; Takahashi K; Ayabe K; Samad R; Fukaya E; Friedmann P; Varma M; Bergmann SR
Br J Haematol; 2011 Aug; 154(3):373-7. PubMed ID: 21615718
[TBL] [Abstract][Full Text] [Related]
35. Think of HIT when thrombosis follows heparin.
Warkentin TE
Chest; 2006 Sep; 130(3):631-2. PubMed ID: 16963651
[No Abstract] [Full Text] [Related]
36. Heparin-induced thrombocytopenia in surgical patients.
Battistelli S; Genovese A; Gori T
Am J Surg; 2010 Jan; 199(1):43-51. PubMed ID: 20103065
[TBL] [Abstract][Full Text] [Related]
37. Heparin-induced thrombocytopenia in pediatrics.
Severin T; Sutor AH
Semin Thromb Hemost; 2001 Jun; 27(3):293-9. PubMed ID: 11446663
[TBL] [Abstract][Full Text] [Related]
38. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
[TBL] [Abstract][Full Text] [Related]
39. Lower extremity manifestations and treatment of heparin-induced thrombocytopenia syndromes: a cohort study.
Bibbo C; Hatfield PS
J Foot Ankle Surg; 2011; 50(1):16-24. PubMed ID: 21055974
[TBL] [Abstract][Full Text] [Related]
40. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome.
Kuitunen A; Suojaranta-Ylinen R; Raivio P; Kukkonen S; Lassila R
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):18-22. PubMed ID: 17289474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]